A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : iPS / induced pluripotent stem

[Related PubMed/MEDLINE]
Total Number of Papers: 1880
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   iPS  (>> Co-occurring Abbreviation)
Long Form:   induced pluripotent stem
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 An iPS-derived in vitro model of human atrial conduction. AF, CV
2022 Analyses of erythropoiesis from embryonic stem cell-CD34+ and cord blood-CD34+ cells reveal mechanisms for defective expansion and enucleation of embryomic stem cell-erythroid cells. CB, CB-ortho, ES, PB, RBCs
2022 Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. ALS
2022 Application of the water-insoluble, temperature-responsive block polymer poly(butyl methacrylate-block-N-isopropylacrylamide) for pluripotent stem cell culture and cell-selective detachment. ---
2022 Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling. MuSCs
2022 Assessing Variant Causality and Severity Using Retinal Pigment Epithelial Cells Derived from Stargardt Disease Patients. dRPE
2022 Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. ALS, DPR, ER, FTD, GSK-3beta
2022 Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming. iXEN, MEFs
2022 Dynamic Features of Chromosomal Instability during Culture of Induced Pluripotent Stem Cells. iPSCs
10  2022 Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice. CDX2, HIOs, UC
11  2022 Establishment of iPS cell line (KLRMMEi002-A) by reprogramming peripheral blood mononuclear cells from a patient with USH2A-associated Usher syndrome. PBMCs, USH2
12  2022 Exposure to a Pathological Condition May Be Required for the Cells to Secrete Exosomes Containing mtDNA Aberration. AD, GBM, mtDNA, NSCs
13  2022 Fluorescent Reporters Distinguish Stem Cell Colony Subtypes During Somatic Cell Reprogramming. iXEN
14  2022 Formation of three-dimensional cell aggregates expressing lens-specific proteins in various cultures of human iris-derived tissue cells and iPS cells. LECs
15  2022 Functional Evaluation of Human Bioengineered Cardiac Tissue Using iPS Cells Derived from a Patient with Lamin Variant Dilated Cardiomyopathy. DCM, LMNA
16  2022 Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming. AML
17  2022 General gene expression patterns and stemness of the gingiva and dental pulp. MSCs
18  2022 Generation and characterization of induced pluripotent stem (iPS) cell line (SDUCTi001-A) using fibroblasts derived from male-healthy donor. ---
19  2022 GFP Tagged VSELs Help Delineate Novel Stem Cells Biology in Multiple Adult Tissues. GFP, hES, MSCs, VSELs
20  2022 HDAC inhibitor and proteasome inhibitor induce cleavage and exosome-mediated secretion of HSP90 in mouse pluripotent stem cells. ES, Hsp90, ROS
21  2022 Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells. ---
22  2022 Human artificial oocytes from patients' somatic cells: past, present and future. ---
23  2022 Human Chorionic Villous Differentiation and Placental Development. ES, FEC, FGR, HDP
24  2022 Human retinal organoids harboring IMPG2 mutations exhibit a photoreceptor outer segment phenotype that models advanced retinitis pigmentosa. IMPG2, OS, ROs, RP
25  2022 Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells. CKD
26  2022 Long-range axonal projections of transplanted mouse embryonic stem cell-derived hypothalamic neurons into adult mouse brain. ES, mESC, PPit
27  2022 Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future. DICT
28  2022 Pramef12 enhances reprogramming into naïve iPS cells. Pramef12
29  2022 Recent Technological Innovations to Promote Cardiovascular Research. AI, CVD
30  2022 Research on Werner Syndrome: Trends from Past to Present and Future Prospects. WS
31  2022 SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes. COVID-19, MOI, SARS-CoV-2
32  2022 Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events. Cas9n, CF, CFTR, HDR, IHR, PB
33  2022 Stem cell membrane-camouflaged targeted delivery system in tumor. MSCs, NPs
34  2022 Stem Cell Technology in Organ Transplantation: A Novel Method for 3D Bioprinting Functional and Stable Liver Grafts Using Human iPS Cells Derived Cells. ---
35  2022 StemPanTox: A fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cells. ES
36  2022 Suspension culture of human induced pluripotent stem cell-derived intestinal organoids using natural polysaccharides. ---
37  2022 The effects of continuous exposure to low-dose chlorine dioxide gas on the characteristics of induced pluripotent stem cells. ---
38  2022 Thermoresponsive block copolymer brush for temperature-modulated hepatocyte separation. PNIPAAm
39  2022 [Development of CAR-T cell therapy using allogeneic iPS cells]. ---
40  2021 A Personalized Glomerulus Chip Engineered from Stem Cell-Derived Epithelium and Vascular Endothelium. ECs
41  2021 A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy. alpha-DG, FKRP, MD, WWS
42  2021 A Versatile In Vivo System to Study Myc in Cell Reprogramming. AAV
43  2021 An exosomal-carried short periostin isoform induces cardiomyocyte proliferation. CPC, Exo, FAK, YAP
44  2021 Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance. HR, VUS
45  2021 Bone Morphogenetic Protein 4 (BMP4) Enhances the Differentiation of Human Induced Pluripotent Stem Cells into Limbal Progenitor Cells. BMP4, PI, RT-PCR
46  2021 BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes. COVID-19, SARS-CoV-2, WHO
47  2021 Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression. CHD, DMSO, miR
48  2021 Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy. DMD
49  2021 Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development. DA, PD
50  2021 Derivation of Ringed Seal (Phoca hispida) Induced Multipotent Stem Cells. ---
51  2021 Design of synthetic promoters for controlled expression of therapeutic genes in retinal pigment epithelial cells. AMD, CMV-IE, PR, RPE
52  2021 Development of platelet replacement therapy using human induced pluripotent stem cells. ---
53  2021 Differentiation of Midbrain Dopaminergic Neurons from Human iPS Cells. ---
54  2021 Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat. DCM, dOex-mIRs, LVEF, MSCs
55  2021 Dual inhibition of TMPRSS2 and Cathepsin Bprevents SARS-CoV-2 infection in iPS cells. ACE2, CTSB, CTSs, SARS-CoV-2, TMPRSSs
56  2021 Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1. ---
57  2021 eIF2B-capturing viral protein NSs suppresses the integrated stress response. cryo-EM, ISR, SFSV
58  2021 Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells. ---
59  2021 Enhanced Osteogenic Differentiation of Pluripotent Stem Cells via gamma-Secretase Inhibition. ESC
60  2021 Establishment of a human induced pluripotent stem cell line (CSUASOi008-A) from a type 2 diabetic patient with retinopathy. DR, PBMCs
61  2021 Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder. ---
62  2021 Gene Expression in Pancreatic Cancer-Like Cells and Induced Pancreatic Stem Cells Generated by Transient Overexpression of Reprogramming Factors. EMT, iTS, qRT-PCR
63  2021 Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells. ---
64  2021 Generation of induced pluripotent stem cell line (KRIBBi004-A) from adult bone marrow CD34+ cells from a patient carrying 46,XX,t(1;5)(p31.1;35.1) karyotype. ---
65  2021 Generation of induced pluripotent stem cell Line KAIMRCi001-A by reprogramming erythroid progenitors from peripheral blood of a healthy Saudi donor. EPCs
66  2021 Generation of Murine Induced Pluripotent Stem Cells through Transposon-Mediated Reprogramming. ES, MEFs
67  2021 Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions. ---
68  2021 Generation of Urine-Derived Induced Pluripotent Stem Cell Line from Patients with Acute Kidney Injury. AKI, HUC-iPS, HUCs, KPCs
69  2021 Genetically edited CD34+ cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells. ---
70  2021 Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity. ---
71  2021 Genome-wide hypermethylation is closely associated with abnormal expression of genes involved in neural development in induced pluripotent stem cells derived from a Down syndrome mouse model. DS
72  2021 Hematopoietic stem cell- and induced pluripotent stem cell-derived CAR-NK cells as reliable cell-based therapy solutions. CAR, CRS, GVHD, NK
73  2021 Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells. TRP-1
74  2021 Human ES and iPS cells display less drug resistance than differentiated cells, and naive-state induction further decreases drug resistance. ES, EST, PSCs
75  2021 Hypothalamic-pituitary organoid generation through the recapitulation of organogenesis. ES
76  2021 In Silico Analysis to Explore Lineage-Independent and -Dependent Transcriptional Programs Associated with the Process of Endothelial and Neural Differentiation of Human Induced Pluripotent Stem Cells. ---
77  2021 In silico-labeled ghost cytometry. ---
78  2021 In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing Technology. CYP3A4, HCV, HLCs, IECs, KO
79  2021 Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS. ALS, FALS, iPSC, LDH, MNs, SOD1
80  2021 Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats. NMR
81  2021 Interactome analysis illustrates diverse gene regulatory processes associated with LIN28A in human iPS cell-derived neural progenitor cells. NPCs
82  2021 iPS cell-based therapy for Parkinson's disease: A Kyoto trial. ---
83  2021 Machine Learning Techniques to Classify Healthy and Diseased Cardiomyocytes by Contractility Profile. TS
84  2021 Macrophage-like iPS-derived Suppressor Cells Reduce Th1-mediated Immune Response to a Retinal Antigen. EAU, hIRBP, IL, SCs
85  2021 MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. CM, CSCs, LLC, miPS
86  2021 Methods to Induce Small-Scale Differentiation of iPS Cells into Dopaminergic Neurons and to Detect Disease Phenotypes. ---
87  2021 Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine. ---
88  2021 Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females†. IVF
89  2021 Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells. ACE2, ES
90  2021 Monitoring PINK1-Parkin Signaling Using Dopaminergic Neurons from iPS Cells. PD
91  2021 Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function. NSC, TM, WFS
92  2021 Myogenic Differentiation of iPS Cells Shows Different Efficiency in Simultaneous Comparison of Protocols. ---
93  2021 NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells. EB, NAMPT, SIRTs
94  2021 Niclosamide affects intracellular TDP-43 distribution in motor neurons, activates mitophagy, and attenuates morphological changes under stress. ALS, TDP-43
95  2021 Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population. ---
96  2021 Novel Technique for Retinal Nerve Cell Regeneration with Electrophysiological Functions Using Human Iris-Derived iPS Cells. ---
97  2021 Pesticides and Parkinson's disease: Current and future perspective. PD, SN
98  2021 Rat-Induced Pluripotent Stem Cells-Derived Cardiac Myocytes in a Cell Culture Dish. EBs
99  2021 Regenerative medicine for radiation emergencies. IAEA EPR-RANET
100  2021 RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway. EMT, GC, GCSCs, RORbeta